{"id":"corticosteroids-for-local-oral-treatment","safety":{"commonSideEffects":[{"rate":null,"effect":"Oral candidiasis"},{"rate":null,"effect":"Local irritation or burning"},{"rate":null,"effect":"Taste disturbance"},{"rate":null,"effect":"Systemic absorption (minimal with local application)"}]},"_chembl":{"chemblId":"CHEMBL2108778","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Corticosteroids bind to glucocorticoid receptors in immune cells and epithelial tissues, suppressing pro-inflammatory cytokine production and reducing local inflammation. When applied topically to oral tissues, they decrease swelling, erythema, and discomfort associated with inflammatory oral conditions. This localized delivery minimizes systemic exposure while targeting the affected area directly.","oneSentence":"Corticosteroids reduce inflammation and suppress immune responses in oral tissues through glucocorticoid receptor activation.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:07:41.992Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Oral inflammatory conditions (e.g., oral lichen planus, aphthous ulcers, oral mucositis)"},{"name":"Local oral inflammation and pain relief"}]},"trialDetails":[{"nctId":"NCT03663335","phase":"PHASE2","title":"Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2018-11-28","conditions":"Kidney Transplantation","enrollment":418},{"nctId":"NCT06859424","phase":"PHASE2","title":"A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation","status":"RECRUITING","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2025-07-25","conditions":"AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category)","enrollment":358},{"nctId":"NCT05811351","phase":"PHASE2","title":"A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2023-03-06","conditions":"Geographic Atrophy","enrollment":305},{"nctId":"NCT07349680","phase":"PHASE3","title":"Ultrasound-Guided Thoracic Paravertebral Block With Steroid and Local Anesthetic for Acute Herpes Zoster: Effects on Pain Control and Prevention of Postherpetic Neuralgia","status":"COMPLETED","sponsor":"Assiut University","startDate":"2023-03-15","conditions":"Postherpetic Neuralgia","enrollment":100},{"nctId":"NCT03568318","phase":"PHASE3","title":"A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2018-08-09","conditions":"Atopic Dermatitis","enrollment":1533},{"nctId":"NCT07278323","phase":"PHASE4","title":"Frozen Shoulder and Hormone Replacement Therapy","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-01-01","conditions":"Adhesive Capsulitis of the Shoulder, Frozen Shoulder","enrollment":60},{"nctId":"NCT03721965","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Itacitinib in Combination With Corticosteroids for Treatment of Graft-Versus-Host Disease in Pediatric Subjects","status":"TERMINATED","sponsor":"Incyte Corporation","startDate":"2019-12-31","conditions":"Acute Graft-versus-host Disease","enrollment":2},{"nctId":"NCT07167251","phase":"","title":"Management of Immune Checkpoint Inhibition-related Hepatitis Using Low-dose Corticosteroids","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-08-25","conditions":"Immune Related Adverse Events, Immune-Mediated Hepatitis, Cancer","enrollment":63},{"nctId":"NCT07074951","phase":"NA","title":"Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy","status":"RECRUITING","sponsor":"St. Petersburg State Pavlov Medical University","startDate":"2013-03-10","conditions":"Primary IgA-nephropathy, High-risk, Caucasians","enrollment":240},{"nctId":"NCT07030881","phase":"NA","title":"Effect of Spacer Use on Exacerbation Risk in High-Risk Older Adults With Chronic Airway Diseases Receiving Triple Therapy","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Ningbo University","startDate":"2025-06-20","conditions":"Asthma, COPD","enrollment":380},{"nctId":"NCT06906315","phase":"PHASE4","title":"Dexamethasone Treatment for Patients Undergoing Endodontics","status":"COMPLETED","sponsor":"University of Salamanca","startDate":"2024-11-04","conditions":"Endodontic Treatment, Pulp Necrosis, Periapical Lesions","enrollment":82},{"nctId":"NCT03564236","phase":"NA","title":"Nasal High-Flow in COPD","status":"RECRUITING","sponsor":"Marieke Duiverman","startDate":"2018-10-01","conditions":"COPD Exacerbation","enrollment":136},{"nctId":"NCT03724903","phase":"NA","title":"Ductal Lavage Versus Corticosteroids Therapy for Idiopathic Granulomatous Mastitis","status":"COMPLETED","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2019-04-01","conditions":"Granulomatous Mastitis","enrollment":140},{"nctId":"NCT06119672","phase":"PHASE3","title":"Efficacy of Probiotic Capsules With Topical Clobetasol Propionate in OLP Treatment","status":"UNKNOWN","sponsor":"October 6 University","startDate":"2023-05-01","conditions":"Oral Lichen Planus","enrollment":36},{"nctId":"NCT03003520","phase":"PHASE2","title":"A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma","status":"COMPLETED","sponsor":"Celgene","startDate":"2017-02-28","conditions":"Lymphoma, Large B-Cell, Diffuse","enrollment":46},{"nctId":"NCT02936505","phase":"NA","title":"Clinical Study Evaluating Two Treatment Protocols for Immunosuppressive Drugs. Looking at 3-year Incidence of CLAD.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vastra Gotaland Region","startDate":"2016-10-12","conditions":"Lung Transplantation, Allografts","enrollment":249},{"nctId":"NCT04903054","phase":"PHASE2","title":"Selective CD28 Blockade in Renal Transplant Recipients","status":"WITHDRAWN","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2022-01-10","conditions":"Kidney Transplantation, Renal Transplant Recipients","enrollment":""},{"nctId":"NCT05112354","phase":"PHASE2","title":"Predictive Factors for Recovery in Idiopathic Sensory Neural Hearing Loss","status":"COMPLETED","sponsor":"Assiut University","startDate":"2019-12-01","conditions":"Idiopathic Sudden SNHL","enrollment":40},{"nctId":"NCT03226899","phase":"PHASE4","title":"A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment","status":"TERMINATED","sponsor":"Ironwood Pharmaceuticals, Inc.","startDate":"2017-07-19","conditions":"Gout, Chronic Kidney Disease (CKD)","enrollment":242},{"nctId":"NCT01729494","phase":"PHASE4","title":"Belatacept Early Steroid Withdrawal Trial","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2012-09","conditions":"Renal Transplantation","enrollment":316},{"nctId":"NCT02930343","phase":"PHASE3","title":"Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate Monotherapy","status":"TERMINATED","sponsor":"Jawaharlal Institute of Postgraduate Medical Education & Research","startDate":"2016-09","conditions":"Rheumatoid Arthritis","enrollment":136},{"nctId":"NCT03345407","phase":"PHASE2","title":"Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2017-11-28","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":943},{"nctId":"NCT02336048","phase":"PHASE1","title":"A Study Evaluating the Safety of Tocilizumab in Addition to Standard of Care Premedication Given Before Obinutuzumab + Chlorambucil in Participants With Untreated B-Cell Chronic Lymphocytic Leukemia (B-CLL) and Comorbidities","status":"TERMINATED","sponsor":"Hoffmann-La Roche","startDate":"2015-06-26","conditions":"B-Cell Chronic Lymphocytic Leukemia","enrollment":38},{"nctId":"NCT04540926","phase":"PHASE1, PHASE2","title":"Cyclosporine A Plus Low-steroid Treatment in COVID-19 Pneumonia","status":"UNKNOWN","sponsor":"Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado","startDate":"2020-09","conditions":"COVID 19 Pneumonia","enrollment":200},{"nctId":"NCT03324503","phase":"NA","title":"A Study to Estimate the Effect Sizes of HRCT Endpoints in Response to Glucocorticoid Induction Therapy in Subjects With Pulmonary Sarcoidosis","status":"COMPLETED","sponsor":"Celgene","startDate":"2017-12-08","conditions":"Sarcoidosis, Pulmonary","enrollment":8},{"nctId":"NCT01380535","phase":"EARLY_PHASE1","title":"Extracorporeal Photopheresis (ECP) With Methoxsalen for Chronic Graft Versus Host Disease (cGVHD)","status":"COMPLETED","sponsor":"Mallinckrodt","startDate":"2011-11","conditions":"Chronic Graft Versus Host Disease","enrollment":60},{"nctId":"NCT02794688","phase":"","title":"Ductal Lavage in Non-lactating Female Women With Mastitis","status":"COMPLETED","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2016-08","conditions":"Mastitis","enrollment":32},{"nctId":"NCT02040584","phase":"PHASE3","title":"A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients.","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2013-12-20","conditions":"Liver Transplant","enrollment":217},{"nctId":"NCT03415165","phase":"EARLY_PHASE1","title":"Efficacy of Green Tea Buccal Tablets in Oral Lichen Planus","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2018-01-03","conditions":"Oral Lichen Planus","enrollment":60},{"nctId":"NCT01998789","phase":"PHASE2","title":"Everolimus Post Orthotopic Liver Transplant","status":"UNKNOWN","sponsor":"Tomoaki Kato","startDate":"2013-10","conditions":"Orthotopic Liver Transplant","enrollment":50},{"nctId":"NCT01900431","phase":"PHASE2","title":"Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis","status":"COMPLETED","sponsor":"Sanofi","startDate":"2013-10","conditions":"Uveitis","enrollment":58},{"nctId":"NCT00634920","phase":"PHASE4","title":"Evaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant Recipients","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2008-03","conditions":"Renal Function","enrollment":204},{"nctId":"NCT01596062","phase":"PHASE2","title":"Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study)","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2012-03","conditions":"Renal Transplantation","enrollment":16},{"nctId":"NCT00455013","phase":"PHASE2","title":"A Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in Subjects Undergoing Kidney Transplantation","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2007-07","conditions":"Disorder Related to Renal Transplantation","enrollment":93},{"nctId":"NCT01079143","phase":"PHASE3","title":"Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant Recipients","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2009-09","conditions":"Renal Interstitial Fibrosis","enrollment":194},{"nctId":"NCT00658320","phase":"PHASE3","title":"Concentration Controlled Everolimus With Reduced Dose Cyclosporine Versus Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids","status":"COMPLETED","sponsor":"Novartis","startDate":"2008-02","conditions":"Kidney Transplantation","enrollment":122},{"nctId":"NCT01429844","phase":"PHASE3","title":"Tacrolimus Versus Cyclosporine for Immunosuppression After Lung Transplantation","status":"COMPLETED","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2001-01","conditions":"Bronchiolitis Obliterans, Immunosuppression","enrollment":274},{"nctId":"NCT00251004","phase":"PHASE3","title":"Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Novartis","startDate":"2005-10","conditions":"Kidney Transplantation, Graft Rejection","enrollment":833}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":24,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["clobetasol probionate in orabase"],"phase":"phase_3","status":"active","brandName":"Corticosteroids for Local Oral Treatment","genericName":"Corticosteroids for Local Oral Treatment","companyName":"October 6 University","companyId":"october-6-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Corticosteroids reduce inflammation and suppress immune responses in oral tissues through glucocorticoid receptor activation. Used for Oral inflammatory conditions (e.g., oral lichen planus, aphthous ulcers, oral mucositis), Local oral inflammation and pain relief.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}